Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Arzeda is raising $5,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Alexandre Zanghellini played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Arzeda

Arzeda, The Protein Design Company, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. .

To learn more about Arzeda, visit http://www.arzeda.com/

Contact:
Alexandre Zanghellini, Chief Executive Officer
206-402-6506
alexandre.zanghellini@arzeda.com
https://www.linkedin.com/in/alexandre-zanghellini/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved